L3 Clinical Trials, the Clinical Research Organization (CRO) division of L3 Healthcare (L3), announces the company is now a certified designer of the Medrio EDC Software. L3 Clinical Trials provides comprehensive and specialized CRO services for start-up and mid-size...
NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it will initiate the Phase I clinical trial of its Stelara® (ustekinumab) biosimilar in the second...
Recognizing the Support of the National Institutes of Health and the HIV Vaccine Trials Network in Advancing GeoVax’s HIV Vaccine Development Efforts GeoVax Labs, Inc. (OTCQB: GOVXD), a biotechnology company developing human vaccines, announced today its observance of...
Placebell technology designed to limit the negative impact of the placebo effect in clinical trials Tools4Patient, S.A., developer of tools to optimize and accelerate drug development programs, today announced it raised €4 million ($4.5 million) in an oversubscribed...
IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies based on its proprietary T-win® technology, announced the initiation of the Phase 2 portion of a global, open-label, randomized clinical trial studying the...
— Clinical Proof-of-Concept Data Expected in Fourth Quarter of 2019 — Dicerna Pharmaceuticals, Inc. (DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the dosing of the first...
Email
Text